Interferon Alpha-2a Therapy in Patients with Refractory Behçet Uveitis
- 8 December 2015
- journal article
- research article
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 25 (1) , 71-75
Abstract
Purpose: To report the results of IFNα2a therapy in patients with Behçet uveitis refractory to azathioprine-cyclosporine combination treatment. Methods: In a retrospective study, 39 patients treated with either azathioprine-cyclosporine combination treatment (group 1, n = 23) or IFNα2a (group 2, n = 16) with a diagnosis of ocular Behçet disease (BD), were included in the study. Group 2 consisted of patients who did not respond to conventional combination therapy, and were therefore treated with IFNα2a. Clinical response and relapse rates were recorded for each group. Results: The mean number of uveitis attacks/year per patient was 0.8 ± 1.6 in Group 1. In Group 2, a significant decrease in the mean number of uveitis attacks/year per patient was observed after initiation of IFNα2a (2.4 ± 1.8 vs 1.3 ± 2.0) (pConclusions: IFNα2a therapy is an effective alternative for Behçet uveitis patients where conventional combination therapy fails.Keywords
This publication has 12 references indexed in Scilit:
- Long‐term remission after cessation of interferon‐α treatment in patients with severe uveitis due to Behçet's diseaseArthritis & Rheumatism, 2010
- Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patientsBritish Journal of Ophthalmology, 2006
- Uveitis in Behçet disease: An analysis of 880 patientsAmerican Journal of Ophthalmology, 2004
- The use of interferon α in behçet disease: review of the literatureSeminars in Arthritis and Rheumatism, 2004
- Human Recombinant Interferon-α2a (rhIFNα2a) for the Treatment of Behçet’s Disease with Sight-Threatening Retinal Vasculitis2003
- Interferon Alfa-2a in the Treatment of Behçet DiseaseArchives of Dermatology, 2002
- Medical Management of Beh et s Syndrome1999
- A Controlled Trial of Azathioprine in Behçet's SyndromeNew England Journal of Medicine, 1990
- DOUBLE-MASKED TRIAL OF CYCLOSPORIN VERSUS COLCHICINE AND LONG-TERM OPEN STUDY OF CYCLOSPORIN IN BEHÇET'S DISEASEThe Lancet, 1989
- Beh et's syndrome: Treatment with recombinant leukocyte alpha-interferonArchives of Dermatological Research, 1986